This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase 1/2a Study Evaluating the Safety, Pharmaco...
Clinical trial

A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Small Cell Lung Cancer (SCLC) or other non-hematological malignancies.

Read time: 1 mins
Last updated:16th Oct 2006
Phase 1: safety assessment, dose limiting toxicity 9DLT) determination, maximum tolerated dose (MTD) determination, pharmacokinetic profile evaluation. Phase 2: safety assessment at the recommended Phase 2 dose (RPTD), preliminary efficacy assessment.
Category Value
Study start date 2006-10-16

View full details